从阿尔茨海默病的遗传相关性到使用人工神经网络模型进行分类
Claudia Cava1,2, Salvatore D'Antona3, Francesca Maselli3
1Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Via F. Cervi 93, Segrate-Milan, 20090, Milan, Italy. claudia.cava@ibfm.cnr.it.
Functional & integrative genomics
|September 8, 2023
概括
研究人员通过遗传分析确定了65种与阿尔茨海默病 (AD) 相关的特征. 一个基本的神经网络模型显示了分析AD基因表达数据的前景,达到66%的准确性.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 计算生物学 计算生物学
背景情况:
- 散发性阿尔茨海默氏病 (AD) 是一种复杂的神经系统疾病,具有许多危险因素.
- 目前对阿尔茨海默病的诊断方法通常耗时,昂贵,侵入性,缺乏一致的准确性.
- 了解AD的遗传基础和识别早期诊断标记对于及时干预至关重要.
研究的目的:
- 使用全基因组关联数据,研究阿尔茨海默病与各种人类特征之间的遗传相关性.
- 用人工神经网络分析AD患者的海马体基因表达特征,以确定潜在的诊断模式.
- 探索早期AD诊断的新方法,并了解其多因素性质.
主要方法:
- 来自AD研究和英国生物库的全基因组关联统计数据用于遗传相关性分析.
- 来自AD患者的海马基因表达数据使用四种不同的人工神经网络模型进行了分析.
- 特性选择方法与5个AD基因表达数据集的神经网络比较一起应用.
主要成果:
- 发现65种特征与阿尔茨海默病有遗传相关性,分为9个群体,包括医疗条件,认知能力,教育和生活方式因素.
- 一个简单的基本神经网络模型在分析AD基因表达数据时,与更复杂的模型相比,显示出更高的性能 (66%的准确性).
- 这些发现突出了AD与广泛的人类特征之间的潜在遗传联系,并建议用于基因表达分析的可行计算方法.
结论:
- 遗传相关性分析揭示了阿尔茨海默病与各种人类特征之间的重要关联.
- 人工神经网络,特别是更简单的模型,显示出在AD研究中分析复杂的基因表达数据的潜力.
- 这项研究有助于更好地了解AD的多因素病因学,并建议改善诊断策略的途径.
相关概念视频
Classification of Neurotransmitters
3.0K
Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...
3.0K
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212


